Literature DB >> 24928268

Impact of complications and hospital-free days on health related quality of life 1 year after radical cystectomy.

Chad R Ritch1, Michael S Cookson2, Sam S Chang3, Peter E Clark3, Matthew J Resnick3, David F Penson3, Joseph A Smith3, Alex T May3, Christopher B Anderson3, Chaochen You3, Haerin Lee3, Daniel A Barocas3.   

Abstract

PURPOSE: We determined the extent to which complications as well as number of hospital-free days within 30 and 90 days of surgery predicted health related quality of life 1 year after radical cystectomy.
MATERIALS AND METHODS: We used data from a prospective health related quality of life study using a validated instrument, the Vanderbilt Cystectomy Index-15. Complications were graded by the Clavien system, and hospital length of stay and length of stay during readmissions were used to calculate 30 and 90-day hospital-free days, respectively. We compared the number of hospital-free days among patients with varying levels of complications. Multivariate analysis was performed to determine predictors of Vanderbilt Cystectomy Index-15 score 1 year after surgery adjusting for demographic (age, gender, comorbidities) and clinical variables (stage and diversion type).
RESULTS: A total of 100 patients with complete baseline and 1-year followup health related quality of life data were included in the analysis. Median (IQR) 30 and 90-day hospital-free days were 24 (22-25) and 84 (82-85), respectively. Patients who experienced any complications had significantly fewer 30-day hospital-free days (22 vs 24 days, p <0.01) and 90-day hospital-free days (81 vs 84 days, p <0.01), and patients with higher grade complications had fewer hospital-free days than those with lower grade or no complications (p <0.01). On multivariate analysis female gender and baseline Vanderbilt Cystectomy Index-15 score independently predicted higher 1-year health related quality of life scores.
CONCLUSIONS: Patients who experience complications after radical cystectomy have fewer 30 and 90-day hospital-free days. However, neither predicts health related quality of life at 1 year. Instead, long-term health related quality of life appears to be driven largely by baseline health related quality of life and gender.
Copyright © 2014 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  complications; cystectomy; length of stay; patient readmission; quality of life

Mesh:

Year:  2014        PMID: 24928268     DOI: 10.1016/j.juro.2014.06.004

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

1.  Prospective evaluation of health-related quality of life after radical cystectomy: focus on peri- and postoperative complications.

Authors:  Alexander Kretschmer; Tobias Grimm; Alexander Buchner; Markus Grabbert; Friedrich Jokisch; Birte-Swantje Schneevoigt; Maria Apfelbeck; Gerald Schulz; Christian G Stief; Alexander Karl
Journal:  World J Urol       Date:  2016-12-23       Impact factor: 4.226

2.  Assessment of health-related quality of life of male patients with ileal orthotopic neobladder compared to cutaneous ureterostomy.

Authors:  Arman Tsaturyan; Mher Beglaryan; Yervand Kirakosyan; Davit Martirosyan; Mher Mkhitaryan; Varujan Shahsuvaryan; Sergey Fanarjyan; Ashot Tsaturyan
Journal:  Cent European J Urol       Date:  2020-05-09

3.  Length of hospital stay and mortality associated with burns from assault: a retrospective study with inverse probability weighting analysis.

Authors:  Ryo Yamamoto; Mitsunobu Toyosaki; Tomohiro Kurihara; Junichi Sasaki
Journal:  Burns Trauma       Date:  2020-04-01

Review 4.  How to lower postoperative complications after radical cystectomy - a review.

Authors:  Wojciech Krajewski; Romuald Zdrojowy; Krzysztof Tupikowski; Bartosz Małkiewicz; Anna Kołodziej
Journal:  Cent European J Urol       Date:  2016-11-30

5.  Determinants and Dynamic Changes of Generic Quality of Life in Human Bladder Cancer Patients.

Authors:  Yuh-Shyan Tsai; Tzu-Yi Wu; Yeong-Chin Jou; Tzong-Shin Tzai; Jung-Der Wang
Journal:  J Clin Med       Date:  2021-11-23       Impact factor: 4.241

6.  Dynamic changes of quality of life in muscle-invasive bladder cancer survivors.

Authors:  Yuh-Shyan Tsai; Tzu-Yi Wu; Chien-Hui Ou; Hong-Lin Cheng; Tzong-Shin Tzai; Wen-Horng Yang; Jung-Der Wang
Journal:  BMC Urol       Date:  2022-08-20       Impact factor: 2.090

7.  Hospital-Free Days: A Pragmatic and Patient-centered Outcome for Trials among Critically and Seriously Ill Patients.

Authors:  Catherine L Auriemma; Stephanie P Taylor; Michael O Harhay; Katherine R Courtright; Scott D Halpern
Journal:  Am J Respir Crit Care Med       Date:  2021-10-15       Impact factor: 30.528

8.  Strategies to Promote ResiliencY (SPRY): a randomised embedded multifactorial adaptative platform (REMAP) clinical trial protocol to study interventions to improve recovery after surgery in high-risk patients.

Authors:  Katherine Moll Reitz; Christopher W Seymour; Jennifer Vates; Melanie Quintana; Kert Viele; Michelle Detry; Michael Morowitz; Alison Morris; Barbara Methe; Jason Kennedy; Brian Zuckerbraun; Timothy D Girard; Oscar C Marroquin; Stephen Esper; Jennifer Holder-Murray; Anne B Newman; Scott Berry; Derek C Angus; Matthew Neal
Journal:  BMJ Open       Date:  2020-09-29       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.